Literature DB >> 15375641

Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat.

Sabina H L de Villiers1, Nina Lindblom, Genadiy Kalayanov, Sandra Gordon, Anette M Johansson, Torgny H Svensson.   

Abstract

We have previously shown that active immunization with the nicotine immunoconjugate IP18-KLH attenuates the reinforcing effects of nicotine, i.e., suppresses the nicotine-induced brain dopamine release and prevents reinstatement of the nicotine-seeking behavior in rats. These effects are thought to be due to an alteration of the kinetics of nicotine distribution by the antibodies, resulting in an attenuated nicotine distribution to the brain. In this study, the distribution of nicotine administered at doses corresponding to those used in our previous studies, was investigated in immunized rats and controls. Male Wistar rats received two immunizations with IP18-KLH in Freund's incomplete adjuvant, 21 days apart, and experiments were performed 7-11 days post-immunization under chloral hydrate anesthesia. Blood samples were collected to determine antibody titer and nicotine selectivity using enzyme-linked immunosorbent assay (ELISA) techniques. The animals received an intravenous nicotine dose and were sacrificed either 3 min or 60 min after nicotine administration. Trunk blood was collected and the brains were removed for analysis of nicotine content. The results showed that immunization against nicotine increases the nicotine concentration in blood and significantly decreases the amount of nicotine that reaches the brain. The present findings thus demonstrate an altered distribution of nicotine after immunization with IP18-KLH. Despite the sustained nicotine binding by the antibodies, the active immunization did not alter the metabolism of nicotine to cotinine, the major nicotine metabolite. In conclusion, the attenuation of the reinforcing effect of nicotine after immunization with IP18-KLH, shown previously, is indeed associated with an altered distribution of nicotine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15375641     DOI: 10.1007/s00210-004-0960-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Quantitation of continine in sera of smokers.

Authors:  J J Langone; H Van Vunakis
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-01

Review 2.  The prospects for immunotherapy in smoking cessation.

Authors:  Wayne Hall
Journal:  Lancet       Date:  2002-10-05       Impact factor: 79.321

3.  Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. I. Theoretical considerations.

Authors:  S P Khor; M Mayersohn
Journal:  Drug Metab Dispos       Date:  1991 Mar-Apr       Impact factor: 3.922

4.  Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. II. Distribution of phencyclidine in the rat.

Authors:  S P Khor; H Bozigian; M Mayersohn
Journal:  Drug Metab Dispos       Date:  1991 Mar-Apr       Impact factor: 3.922

5.  Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations.

Authors:  N L Benowitz; H Porchet; P Jacob
Journal:  Prog Brain Res       Date:  1989       Impact factor: 2.453

6.  Immunization of rats reduces nicotine distribution to brain.

Authors:  Y Hieda; D E Keyler; J T VanDeVoort; R S Niedbala; D E Raphael; C A Ross; P R Pentel
Journal:  Psychopharmacology (Berl)       Date:  1999-04       Impact factor: 4.530

7.  A vaccine for nicotine dependence: targeting the drug rather than the brain.

Authors:  Paul Pentel; David Malin
Journal:  Respiration       Date:  2002       Impact factor: 3.580

8.  Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats.

Authors:  N Lindblom; S H L de Villiers; G Kalayanov; S Gordon; A M Johansson; T H Svensson
Journal:  Respiration       Date:  2002       Impact factor: 3.580

9.  Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell.

Authors:  S H L de Villiers; N Lindblom; G Kalayanov; S Gordon; A Malmerfelt; A M Johansson; T H Svensson
Journal:  Respiration       Date:  2002       Impact factor: 3.580

10.  Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum.

Authors:  N L Benowitz; H Porchet; L Sheiner; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1988-07       Impact factor: 6.875

View more
  13 in total

Review 1.  Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.

Authors:  Mark G LeSage; Daniel E Keyler; Paul R Pentel
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

2.  Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum.

Authors:  Sabina H L de Villiers; Katherine E Cornish; Andrew J Troska; Marco Pravetoni; Paul R Pentel
Journal:  Vaccine       Date:  2013-10-29       Impact factor: 3.641

3.  Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs.

Authors:  Nina Lindblom; Sabina H L de Villiers; Svetlana Semenova; Genadiy Kalayanov; Sandra Gordon; Björn Schilström; Anette M Johansson; Athina Markou; Torgny H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-15       Impact factor: 3.000

4.  Vaccination against weight gain.

Authors:  Eric P Zorrilla; Shinichi Iwasaki; Jason A Moss; Jason Chang; Jonathan Otsuji; Koki Inoue; Michael M Meijler; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

5.  Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.

Authors:  M L Miller; S M Aarde; A Y Moreno; K M Creehan; K D Janda; M A Taffe
Journal:  Drug Alcohol Depend       Date:  2015-06-19       Impact factor: 4.492

6.  A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats.

Authors:  Michelle L Miller; Amira Y Moreno; Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Brittani D Vaillancourt; M Jerry Wright; Kim D Janda; Michael A Taffe
Journal:  Biol Psychiatry       Date:  2012-10-23       Impact factor: 13.382

7.  Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers.

Authors:  Irina Esterlis; Jonas O Hannestad; Evgenia Perkins; Frederic Bois; D Cyril D'Souza; Rachel F Tyndale; John P Seibyl; Dorothy M Hatsukami; Kelly P Cosgrove; Stephanie S O'Malley
Journal:  Am J Psychiatry       Date:  2013-04       Impact factor: 18.112

8.  The effect of a chimeric human/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats.

Authors:  Andrew B Norman; Mantana K Norman; William R Buesing; Michael R Tabet; Vladimir L Tsibulsky; William J Ball
Journal:  J Pharmacol Exp Ther       Date:  2008-12-16       Impact factor: 4.030

9.  Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats.

Authors:  Samuel A Roiko; Andrew C Harris; Mark G LeSage; Daniel E Keyler; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2009-04-23       Impact factor: 3.533

10.  Enhanced immunogenicity of a bivalent nicotine vaccine.

Authors:  D E Keyler; S A Roiko; C A Earley; M P Murtaugh; P R Pentel
Journal:  Int Immunopharmacol       Date:  2008-07-24       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.